If approved, drug will become first treatment for PFIC patients in the US and EU More: Albireo submits rare liver disease med odevixibat to FDA and EMA Source: News
read moreNew treatment could prevent debilitating side effects of standard major surgery More: CRUK researchers develop new early-stage rectal cancer treatment Source: News
read moreALK inhibitor recommended in the first-line non-small cell lung cancer setting More: Alunbrig scores NICE backing for ALK-positive lung cancer Source: News
read morePotential availability of vaccine now delayed to the end of 2021 More: Sanofi, GSK face COVID-19 vaccine trial delay Source: News
read moreRoche yields to cancer biosim competition by offering ‘relevant’ discounts: report aliu Thu, 12/10/2020 – 10:53 More: Roche yields to cancer biosim competition by offering 'relevant' discounts: report Source: fierce
read moreAstraZeneca, J&J COVID-19 shots must succeed to meet U.S. vaccination goal: Slaoui arlene.weintraub Thu, 12/10/2020 – 10:51 More: AstraZeneca, J&J COVID-19 shots must succeed to meet U.S. vaccination goal: Slaoui Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals